TITLE

D-dimer levels < 250 ng/mL after oral anticoagulation predicted a low risk for recurrent venous thromboembolism: COMMENTARY

AUTHOR(S)
Kovacs, Michael J.
PUB. DATE
March 2004
SOURCE
ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p50
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on a study conducted to analyze the association of the levels of D-dimers with the risk of recurrent venous thromboembolism (VTE). Patients with a first episode of unprovoked VTE are at greater risk for recurrence than those who have transient risk factors. The minimum duration of oral anticoagulant therapy (OAT) for such patients is 6 months, but ongoing debate exists about whether indefinite OAT is required. The study adds to the evidence that patients with persistent elevation of D-dimer levels are at greater risk for recurrence than those who have normal D-dimer levels.
ACCESSION #
12597149

 

Related Articles

  • Benefits of Novel Oral Anticoagulant Agents for Thromboprophylaxis after Total Hip or Knee Arthroplasty. Friedman, Richard J. // American Health & Drug Benefits;Mar/Apr2012, Vol. 5 Issue 2, p115 

    Background: The incidence of venous thromboembolism (VTE) after total hip arthroplasty (THA) or total knee arthroplasty (TKA) is reduced by the use of thromboprophylactics, such as vitamin K antagonists, low-molecular-weight heparin (LMWH), or fondaparinux. However, these agents have a number of...

  • Update on the prevention of venous thromboembolism. Haines, Stuart T. // American Journal of Health-System Pharmacy;12/1/2004 Supplement, Vol. 61, pS5 

    Purpose: The risk factors for venous thromboembolism (VTE), recommendations for risk stratification and prophylaxis of VTE based on risk, nonpharmacologic and pharmacologic interventions used for prophylaxis, and clinical controversies surrounding VTE prophylaxis are discussed. Summary: Risk...

  • Improving the use of anticoagulant therapies in acutely ill medical patients. Dobesh, Paul P.; Phillips, Katherine W.; Haines, Stuart T. // American Journal of Health-System Pharmacy;8/1/2008 Supplement, Vol. 65, ps5 

    Purpose. Assessment of risk for the development of venous thromboembolism (VTE), selection of VTE prophylaxis in medical patients, strategies for improving prescribing practices to prevent VTE, and the impact of pharmacist-managed anticoagulation services are described; case studies are used to...

  • Thrombosis prophylaxis prior to surgery. Bergqvist, D // Phlebology;2003, Vol. 18 Issue 3, p106 

    This review article provides an update on risk factors of venous thromboembolism and methods for preventing its occurrence following surgery. A summary of the prophylactic methods that are currently available is provided, with particular attention given to low molecular weight heparins, which...

  • Gender Differences with Anticoagulation Discontinuation.  // Clinical Oncology Alert;Oct2008 Pharmacology Watch, p1 

    The article discusses a study on gender differences with anticoagulation discontinuation. The study suggests that women with minimal risk factors may safely stop anticoagulation after six months of therapy. It was found that a higher percentage of women had zero or one of the risk factors for...

  • Efficiency of Systematic Thrombophilia Screening in Idiopathic Venous Thrombosis: A Prospective Study in Internal Medicine. Pottier, P.; Cormier, G.; Truchaud, F.; Planchon, B. // Clinical & Applied Thrombosis/Hemostasis;Jul2005, Vol. 11 Issue 3, p243 

    In case of unprovoked venous thromboembolism (VTE), the screening of thrombophilia is recommended whatever the age of the patient and the type of risk factors (RF). This prospective study was conducted in patients with unprovoked VTE to detect some predictive factors to have a higher risk of...

  • Anticoagulation therapy the answer to treating and preventing thromboembolic disease in children. Adis International Limited // Drugs & Therapy Perspectives;Jan2005, Vol. 21 Issue 1, p6 

    Deals with the efficacy of anticoagulation therapy in treating infants and children with thromboembolic disease (TED). Sites affected in TED; Risk factors for TED in children; Dosage guidelines for paediatric patients; Advantages of low molecular weight heparins over unfractionated heparin.

  • Pharmacological thromboprophylaxis and total hip or knee replacement. Frostick, Simon // British Journal of Nursing;1/14/2016, Vol. 25 Issue 1, p45 

    Pharmacological and mechanical thromboprophylaxis reduces the risk of venous thromboembolism (VTE) in patients undergoing total knee/hip replacement (TKR/THR). Nurses play a key role in VTE prevention through clinical care, before and after discharge from hospital, and patient education....

  • Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question. Douketis, James D. // Mayo Clinic Proceedings;Jun2008, Vol. 83 Issue 6, p628 

    The article presents the author's perspective on a study concerning the perioperative practice of administering bridging anticoagulation with subcutaneous low-molecular-weight heparin (LMWH). He remarks that the novel aspect of the study is the inclusion of a comparison group of patients who did...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics